Institut Català de la Salut - ICS: Recent submissions
Now showing items 21-25 of 5735
-
Cabozantinib plus Atezolizumab in Advanced, Progressive Endocrine Malignancies: A Multicohort, Basket, Phase II Trial (CABATEN/GETNE-T1914)
(American Association for Cancer Research, 2025-11-15) -
Operative and Oncological Outcomes of Vascular Resection and Reconstruction for Perihilar Cholangiocarcinoma
(Springer Nature, 2025-12) -
Positive cerebrospinal fluid in the 2024 McDonald criteria for multiple sclerosis
(Elsevier, 2025-10)



